SYZ Cell Therapy Co.. Report issue

For profit Phase 1 Phase 2
Founded: Hong Kong Hong Kong (2015)

Organization Overview

First Clinical Trial
2015
NCT02026362
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

SYZ Cell Therapy Co..